New hope for MSA patients: drug may reduce dizzy spells and falls
NCT ID NCT02071459
First seen Apr 11, 2026 · Last updated Jun 18, 2026 · Updated 8 times
Summary
This study tested a drug called droxidopa (L-threo DOPS) in 107 adults with multiple system atrophy (MSA) who experience dizziness or fainting when standing up due to low blood pressure. Participants received either the drug or a placebo for 12 weeks. The goal was to see if the drug could reduce these symptoms and improve daily life. The trial is complete, and results help doctors understand if this treatment is helpful for managing this challenging symptom.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MULTIPLE SYSTEM ATROPHY are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
CHRU de lille
Lille, 59037, France
-
CHU Pontchaillou
Rennes, 35033, France
-
CHU bordeaux
Bordeaux, France
-
CHU de Clermont-Ferrand
Clermont-Ferrand, 63000, France
-
CHU de Dijon
Dijon, 21000, France
-
CHU de Poitiers
Poitiers, 86021, France
-
CHU de Rouen
Rouen, 76031, France
-
CHU de limoges
Limoges, 87042, France
-
Centre hospitalier d'Angers
Angers, 49933, France
-
Hôpital G. & R. Laennec
Nantes, 44093, France
-
Hôpital La Timone
Marseille, 13000, France
-
Hôpital Pitié-Salpétrière
Paris, 75013, France
-
chu de Strasbourg
Strasbourg, 67091, France
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.